SAMH
AVEO

Shanda Asset Management Holdings’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Shanda Asset Management Holdings’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,600
Closed -$147K – 115
2020
Q2 		$147K Buy
+28,600
New +$181K 0.01% 91

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Shanda Asset Management Holdings's AVEO Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2020, closing a stake of 28,600 shares — an estimated $147K sold.

Shanda Asset Management Holdings first reported a position in AVEO in Q2 2020 and held it in 1 quarter. The position peaked at $147K in Q2 2020. 63 funds tracked by Wall St. Rank hold AVEO as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 28,600 AVEO Pharmaceuticals, Inc. shares in Q3 2020, an estimated $147K.
  • Shanda Asset Management Holdings first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's AVEO Pharmaceuticals, Inc. position peaked at $147K in Q2 2020.
  • 63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.